DE MARCHI, ROBERTA
DE MARCHI, ROBERTA
DMED - DIPARTIMENTO DI MEDICINA
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group
2023-01-01 Barila, G.; Quaglia, F. M.; Furlan, A.; Pescosta, N.; Bonalumi, A.; Marcon, C.; Pascarella, A.; Tinelli, M.; De March, E.; Lico, A.; Sartori, R.; Clissa, C.; De Sabbata, G.; Nappi, D.; Porrazzo, M.; De Marchi, R.; Pavan, L.; Tosetto, A.; Gherlinzoni, F.; Krampera, M.; Bassan, R.; Patriarca, F.; Semenzato, G.; Zambello, R.
Cytomegalovirus Prophylaxis versus Pre-emptive Strategy: Different CD4+ and CD8+ T Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation: CMV Pre-emptive Treatment versus Prophylaxis
2021-01-01 Sperotto, A.; Candoni, A.; Gottardi, M.; Facchin, G.; Stella, R.; De Marchi, R.; Michelutti, A.; Cavallin, M.; Rosignoli, C.; Patriarca, F.; Fanin, R.
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax
2023-01-01 Candoni, A.; Lazzarotto, D.; Papayannidis, C.; Piccini, M.; Nadali, G.; Dargenio, M.; Riva, M.; Fracchiolla, N.; Mellillo, L.; Dragonetti, G.; Del Principe, M. I.; Cattaneo, C.; Stulle, M.; Pasciolla, C.; De Marchi, R.; Delia, M.; Tisi, M. C.; Bonuomo, V.; Sciume, M.; Spadea, A.; Sartor, C.; Griguolo, D.; Buzzatti, E.; Basilico, C. M.; Sarlo, C.; Piccioni, A. L.; Cerqui, E.; Lessi, F.; Olivieri, A.; Fanin, R.; Luppi, M.; Pagano, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group | 1-gen-2023 | Barila, G.; Quaglia, F. M.; Furlan, A.; Pescosta, N.; Bonalumi, A.; Marcon, C.; Pascarella, A.; Tinelli, M.; De March, E.; Lico, A.; Sartori, R.; Clissa, C.; De Sabbata, G.; Nappi, D.; Porrazzo, M.; De Marchi, R.; Pavan, L.; Tosetto, A.; Gherlinzoni, F.; Krampera, M.; Bassan, R.; Patriarca, F.; Semenzato, G.; Zambello, R. | |
| Cytomegalovirus Prophylaxis versus Pre-emptive Strategy: Different CD4+ and CD8+ T Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation: CMV Pre-emptive Treatment versus Prophylaxis | 1-gen-2021 | Sperotto, A.; Candoni, A.; Gottardi, M.; Facchin, G.; Stella, R.; De Marchi, R.; Michelutti, A.; Cavallin, M.; Rosignoli, C.; Patriarca, F.; Fanin, R. | |
| Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax | 1-gen-2023 | Candoni, A.; Lazzarotto, D.; Papayannidis, C.; Piccini, M.; Nadali, G.; Dargenio, M.; Riva, M.; Fracchiolla, N.; Mellillo, L.; Dragonetti, G.; Del Principe, M. I.; Cattaneo, C.; Stulle, M.; Pasciolla, C.; De Marchi, R.; Delia, M.; Tisi, M. C.; Bonuomo, V.; Sciume, M.; Spadea, A.; Sartor, C.; Griguolo, D.; Buzzatti, E.; Basilico, C. M.; Sarlo, C.; Piccioni, A. L.; Cerqui, E.; Lessi, F.; Olivieri, A.; Fanin, R.; Luppi, M.; Pagano, L. |